Health care regulation firm Frier Levitt has analyzed FDA enforcement actions against “investigation only” peptide vendors. Their summary: the FDA considers a product’s classification determined by its intended use, not its disclaimers. When Internet sites incorporate dosage guides, reconstitution Directions, or backlink to forums talking abo